PTC Therapeutics Inc. News
Sarepta Shares Keep Climbing and PTC Therapeutics Bounces Back
Sarepta adds another 7% on top of nearly 40% gains on Tuesday following good results for a new gene therapy.
Biotech Firm Sarepta Surges 40% on Positive Test Results
But rival firm PTC Therapeutics tumbles nearly 31% on the news.
PTC shares skyrocket on positive data for spinal muscular atrophy drug
Updated interim data from a study of risdiplam were presented June 16 at the 22nd Annual SMA Researcher Meeting.
Solid Biosciences Soars 41% in IPO Despite Late Disclosure About FDA Letter
Solid Bioscience planned its IPO for months, but waited until the day before its market debut on Friday, Jan. 26, to tell investors about an FDA hold on its key drug candidate.
No Good Stock Left Behind: Cramer's 'Mad Money' Recap
Jim Cramer says some sellers are making a big mistake by not giving top-notch CEOs the benefit of the doubt despite earnings upheaval.
Hertz Global Holdings, Honeywell, PetMed Express, Allergan: 'Mad Money' Lightning Round
Jim Cramer is bullish on Hertz Global Holdings, Honeywell, PetMed Express, and Allergan.
Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms
Albany Molecular Research, Acorda Therapeutics and PTC Therapeutics were among the biotech stock movers in premarket trading on Tuesday.
Tesla Chart Faces Key Hurdle. Here's What Happens If It Fails.
Tesla stock faces a key hurdle on the charts. Here's what happens if resistance rejects it.
Tim Cook and Apple Make a Move That Could Annoy China
iPhone maker wants to diversify its supply chain and expand in a crucial market.